CALTH. Inc Logo

CALTH. Inc

Develops in vitro diagnostic tools for point-of-care and self-testing.

402420 | KO

Overview

Corporate Details

ISIN(s):
KR7402420004
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 54, 321호(시흥동, 기업성장센터), 성남시

Description

CALTH Inc. is an in vitro diagnostics (IVD) company that develops and manufactures diagnostic tools. The company specializes in point-of-care testing (POCT), self-testing, and precision medicine, aiming to provide fast, accurate, and cost-effective solutions for disease detection. CALTH's operations are centered on two core proprietary technologies: an "Engineered Nanotrap" for high-sensitivity sample preprocessing and a deep learning-based analysis algorithm for its Lateral Flow Assay products. Through these innovations, the company seeks to improve quality of life by creating value from its diagnostic platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-22 00:00
주주총회소집공고
Korean 38.4 KB
2024-12-24 00:00
주주총회소집결의
Korean 6.1 KB
2024-12-24 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-10-24 00:00
기업설명회(IR)개최결과
Korean 6.8 KB
2024-09-27 00:00
임시주주총회결과
Korean 7.7 KB
2024-09-12 00:00
주주총회소집공고
Korean 41.4 KB
2024-08-20 00:00
주주총회소집결의
Korean 8.4 KB
2024-08-20 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-05-10 00:00
기업설명회(IR)개최결과
Korean 6.8 KB
2024-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB
2024-03-28 00:00
정기주주총회결과
Korean 23.7 KB
2024-03-20 00:00
사업보고서 (2023.12)
Korean 912.7 KB
2024-03-19 00:00
감사보고서제출
Korean 9.6 KB
2024-03-13 00:00
주주총회소집공고
Korean 115.4 KB

Automate Your Workflow. Get a real-time feed of all CALTH. Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CALTH. Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CALTH. Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.